Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.
Type:
Grant
Filed:
June 13, 2018
Date of Patent:
December 7, 2021
Assignee:
BARD1 LIFE SCIENCES LIMITED
Inventors:
Solomzi Makohliso, Irmgard Irminger-Finger, Fernando Herrera
Abstract: The present invention relates to a long non-coding BARD1 RNA molecule named BARD1 9?L. The present invention also relates to siRNAs for therapeutic use, for example, the regulation of BARD1 expression by non-coding RNA. The present invention further relates to methods for the detection of BARD1 9?L. Finally, the present invention relates to promoters driving the expression of BARD1 9?L.
Abstract: The invention relates to the novel long non-coding BARD1 RNA molecule BARD1 9?L, siRNAs for therapeutic use and methods for the detection of BARD1 9?L as well as a promoters driving the expression of BARD1 9?L.
Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.
Type:
Application
Filed:
June 13, 2018
Publication date:
October 25, 2018
Applicant:
BARD1 LIFE SCIENCES LIMITED
Inventors:
Solomzi MAKOHLISO, Irmgard IRMINGER-FINGER, Fernando HERRERA
Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.
Type:
Grant
Filed:
September 23, 2011
Date of Patent:
July 10, 2018
Assignee:
BARD1 LIFE SCIENCES LIMITED
Inventors:
Solomzi Makohliso, Irmgard Irminger-Finger, Fernando Herrera